Escrito por estudiantes que aprobaron Inmediatamente disponible después del pago Leer en línea o como PDF ¿Documento equivocado? Cámbialo gratis 4,6 TrustPilot
logo-home
Document preview thumbnail
Vista previa 4 fuera de 123 páginas
Examen

NR546 Final Exam Questions with Detailed Verified Answers

Document preview thumbnail
Vista previa 4 fuera de 123 páginas

NR546 Final Exam Questions with Detailed Verified Answers

Vista previa del contenido

NR546 Final Exam Questions with Detailed
Verified Answers
Pharmacologic Treatment of Bipolar Disorder Ans: Lithium

Anticonvulsants

Second generation antipsychotics

Unipolar depression Ans: major depressive disorder (MDD)

one of the most common mental disorders

-Approximately 7.1% of adults in the U.S. had episode in last year, prevalence highest
(13.1%) among individuals aged 18-25



S/S

-depressed mood

-loss of interest or pleasure in daily activities

-irritability

-withdrawal

-problems with sleep, eating, energy, concentration, or self-worth

-severe depression: may experience thoughts of suicide or psychotic symptoms.

Bipolar disorder (BD) Ans: Chronic condition characterized by extreme fluctuations
in mood, energy, and ability to function

,-Moods may be manic, hypomanic, or depressed and may include mixed mood or
psychotic features

-many have only experienced only one manic episode in their lifetime

-Mood fluctuations may be separated by periods of high stability or may cycle rapidly

-diagnosed when a client has one or more episodes of mania or hypomania with a
history of one or more major depressive episodes

-high risk for suicide

mania Ans: characterized by a persistently elevated, expansive, or irritable mood.
Related symptoms may include inflated self-esteem, increased goal-directed activity or
energy, including grandiosity, decreased need for sleep, excessive talkativeness, racing
thoughts, flight of ideas (FOI), distractibility, psychomotor agitation, and a propensity
to be involved in high-risk activities. Mania leads to significant functional impairment
and may include psychotic features or necessitate hospitalization

Bipolar Type I: Ans: requires at least one episode of mania for at least one week (or
any duration if hospitalization due to symptoms is required)

Bipolar Type II: Ans: diagnosis requires a current or past hypomanic episode and a
current or past major depressive episode. Symptoms last for at least 4 days but fewer
than seven.

-Hypomanic symptoms are not of sufficient duration or severity to cause significant
functional impairment, psychosis, or hospitalization.

-Anger and irritability are common.

-Clients often enjoy the elevation of mood and are reluctant to report these
symptoms, making bipolar more difficult to diagnose if the client presents in the
depression phase.



© Get it right 2025 Getaway - Stuvia US All rights reserved

,Cyclothymia: Ans: involves the chronic presentation of hypomanic and depressive
symptoms that do not meet the diagnostic criteria for a major depressive or
manic/hypomanic episode.

If bipolar depression is mistaken for MDD: Ans: antidepressant therapy may
precipitate a manic episode or induce rapid-cycling bipolar depression

-may contribute to the increased incidence of death by suicide in children and adults
younger than 25

Antidepressants are used cautiously in clients with bipolar disorder and never as
________________. Ans: monotherapy

-Antidepressants should be combined with a mood stabilizer to prevent the onset of a
hypomanic or manic episode

DA, NE Dysfunction causes what mood related symptoms Ans: Decreased positive
affect:

depressed mood

loss of joy

lack of interest

loss of energy

decreased alertness

decreased self-confidence

appetite changes

5HT, NE Dysfunction causes what mood related symptoms Ans: Increased negative
affect:


© Get it right 2025 Getaway - Stuvia US All rights reserved

, depressed mood

guilt

fear/anxiety

hostility

irritability

loneliness

appetite changes

monoamine hypothesis of depression Ans: -depression occurs as a result of a
deficiency of one or all three monoamine transmitters

• serotonin, norepinephrine, and dopamine

-while mania may result from an excess

Medication Management for Depression, First-Line Treatment: Ans: • Selective
Serotonin Reuptake Inhibitors (SSRIs)

• Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

• Norepinephrine Dopamine Reuptake Inhibitors (NDRI)

• Serotonin Antagonist and Reuptake Inhibitors (SARIs)

SSRI's Ans: Mechanism of action

• inhibit 5-HT reuptake

Adverse effects


© Get it right 2025 Getaway - Stuvia US All rights reserved

Información del documento

Subido en
25 de octubre de 2025
Número de páginas
123
Escrito en
2025/2026
Tipo
Examen
Contiene
Preguntas y respuestas
$22.99

¿Documento equivocado? Cámbialo gratis Dentro de los 14 días posteriores a la compra y antes de descargarlo, puedes elegir otro documento. Puedes gastar el importe de nuevo.
Escrito por estudiantes que aprobaron
Inmediatamente disponible después del pago
Leer en línea o como PDF

Seller avatar
Los indicadores de reputación están sujetos a la cantidad de artículos vendidos por una tarifa y las reseñas que ha recibido por esos documentos. Hay tres niveles: Bronce, Plata y Oro. Cuanto mayor reputación, más podrás confiar en la calidad del trabajo del vendedor.
Shinnie
3.6
(7)
Vendido
24
Seguidores
0
Artículos
4121
Última venta
2 meses hace


Por qué los estudiantes eligen Stuvia

Creado por compañeros estudiantes, verificado por reseñas

Calidad en la que puedes confiar: escrito por estudiantes que aprobaron y evaluado por otros que han usado estos resúmenes.

¿No estás satisfecho? Elige otro documento

¡No te preocupes! Puedes elegir directamente otro documento que se ajuste mejor a lo que buscas.

Paga como quieras, empieza a estudiar al instante

Sin suscripción, sin compromisos. Paga como estés acostumbrado con tarjeta de crédito y descarga tu documento PDF inmediatamente.

Student with book image

“Comprado, descargado y aprobado. Así de fácil puede ser.”

Alisha Student

Preguntas frecuentes